Skip to main content
. 2020 Mar 11;59(8):3801–3813. doi: 10.1007/s00394-020-02211-6

Table 1.

Systematic review study characteristics

Author and year Study name and location Study design Cases Total N (cohorts) or controls or sub-cohort Years of follow-up Sex (% men) Age range (at baseline for cohorts) Exposures measured Outcome Adjusted covariates Statistic NOS score
Arendt 2013 Denmark Cohort 445 333,667 Median 3.5 41% IQR 40.2–69.2 Plasma B12 Kidney Age, sex, calendar year SIR 4.0
Aune 2010 Uruguay Case–control 114 2032 N/A 66%

23–89 (cases)

22–89 (controls)

Dietary B9 Kidney Age, sex, BMI, smoking, alcohol, energy intake, calcium, iron, fibre, mate drinking, intake of vitamins B6, C, and E, and carotenoids, education, income, urban/rural residence, interviewer OR 6.0
Bock 2018 The US Kidney Cancer Study (USA) Case–control 1142 1154 N/A 55% 20–79 Dietary B1, B2, B3, B6, B9, B12 RCC Age, sex, BMI, smoking, alcohol, energy intake, hypertension, family history, education, region, race OR 6.0
Bosetti 2006 Italy Case–control 767 1534 N/A 64%

24–79 (cases)

22–79 (controls)

Dietary B1, B2, B3, B6, B9 RCC Age, sex, BMI, smoking, alcohol, family history, education, centre, period of interview OR 8.0
Brock 2012 Iowa, USA Case–control 323 1827 N/A 67% 40–85 dietary B9 RCC Age, sex, BMI at age 40, smoking, alcohol, energy intake, fatty spreads consumption, hypertension, proxy status OR 7.0
Cho 2013 NHS (USA) Cohort 225 77,208 24 0% 30–55 Total intake B6, B9, B12, methionine RCC Age, BMI, smoking, alcohol, energy intake, fruit and vegetable consumption, hypertension, diabetes, parity calendar time RR 5.5
Cho 2013 HPFS (USA) Cohort 211 47,886 22 100% 40–75 Total intake B6, B9, B12, methionine RCC Age, BMI, smoking, alcohol, energy intake, fruit and vegetable consumption, hypertension, diabetes, calendar time RR 5.5
Gibson 2010 ATBC (Finland) Nested case–control 224 Not reported Not reported 100% 50–69 Serum B2, B6, B9 B12, homocysteine RCC All nutrients: age, BMI and smoking; B9 only: protein and fat intake; B6, B2, and homocysteine only: serum B9; B12 only: protein, leisure time physical activity and serum B9; alcohol checked but not included as not found to be a confounder OR 7.0
Hu 2003 NECSS (Canada) Case–control 1110 4708 N/A 51% 20–70+ B-complex supplements RCC Age, BMI, smoking, alcohol, education, province OR 7.0
Johansson 2014 EPIC (Europe) Nested case–control 556 556 matched; 553 unmatched Not reported Matched 56%; unmatched 68% Not reported Plasma B2, B6, B9, B12, methionine, homocysteine RCC Age, sex, waist-to-hip ratio, smoking, plasma cotinine, alcohol, hypertension, education, country OR 8.5
Johansson 2014 MCCS (Australia) Nested case–control 144 144 Not reported Both, % men not specified 40–79 Plasma B6 RCC Age, sex, waist-to-hip ratio, smoking, plasma cotinine, alcohol, hypertension, education, country OR 9.0
Nicodemus 2004 Iowa Women's Health Study (USA) Cohort 124 34,637 15 0% 55–69 Dietary B1, B2, B6 Kidney Age RR 5.0
Prineas 1997 Iowa Women's Health Study (USA) Cohort 62 35,192 8 0% 55–69 Dietary B1, B2, B6 RCC Age RR 4.0
Schouten 2016 NLCS (The Netherlands) Case–cohort 498 3980 20.3 49% 55–69 Dietary B9 RCC Age, sex, BMI, smoking, alcohol, energy intake, intake of methionine and B2 and B6, hypertension HR 8.0
Tavani 2012 Italy Case–control 767 1534 N/A 64% Not reported Dietary B9 Kidney Age, sex, BMI, smoking, alcohol, energy intake, education, study centre, year of interview, physical activity at work OR 5.0

NHS, Nurses’ Health Study; HPFS, The Health Professionals Follow-up Study; ATBC, Alpha-Tocopherol Beta-Carotene Cancer Prevention Study; NECSS, National Enhanced Cancer Surveillance System; EPIC, European Prospective Investigation into Cancer and Nutrition; MCCS, Melbourne Collaborative Cohort Study; NLCS, The Netherlands Cohort Study on Diet and Cancer